14 January, 2026
2026 AMTAR Symposium: The preclinical pipeline: radiochemistry from concept to clinic
Plenary: PROF JASON LEWIS
Deputy Director, Sloan Kettering Institute – OSET; Emily Tow Chair in Oncology, Memorial Sloan Kettering Cancer Center
11 am – 5:30 pm
Seminar Room AIBN, Building 75, UQ St Lucia Campus
Register to receive the Zoom link
DETAILS:
Panel session
Invited Speakers
Networking Event
11:00 – 12:00 – PLENARY – Professor Jason Lewis (Memorial Sloan Kettering Cancer Center) “Radiopharmaceutical Chemistry – Precision Medicine in Cancer Treatment”
12:00 – 1:00 – Lunch
1:00 – 2:00 – Session 1
Prof Rachel Codd “Machining Chelators to Expand Targeted Radiopharmaceuticals”
Dr Benedict Lum “Repurposing antibody-drug conjugates into radiopharmaceuticals for the treatment of bladder cancer”
Dr Melyssa Grieve “Designing new chelators for targeted alpha therapy”
2:00 – 2:30 – Panel session (Prof Jason Lewis, MSKCC; Dr Ben Hughes, Translation Innovation Australia; Prof Ros Francis, RBWH; Dr Ellen van Dam, Clarity Pharmaceuticals) Moderator: Dr James Wood
2:30 – 3:00 – Afternoon Tea
3:00 – 4:00 – Session 2
Dr Nick Fletcher “Pretargeting of PEG-based radiopharmaceutical nanomedicines – balancing stealth vs targeting”
Dr Pie Huda “Small antibody formats in radiopharmaceuticals; discovery and engineering”
Dr James Humphries “Real-Time Imaging of Protein Expression and the Host Immune Response Following mRNA Vaccination”
4:30 – 5:30 – Networking (Level 5 Centre for Advanced Imaging)
Date & Time
14 January, 2026Location
Seminar Room AIBN, Building 75, UQ St Lucia CampusProf Jason Lewis
Deputy Director, Sloan Kettering Institute